$RVXCF lots more news to come soon: I just blog
Post# of 98044
I just blogged on the $87 million CDN investment from leading Chinese Pharma Co Shenzhen Hepalink:
http://www.avoidthebag.com/2017/12/chinese-in...ogixs.html
Tonight I'll be publishing another updating the short interest through to November 30th, and if the trend of the past 6 months continues I expect to see more evidence of bears running for the hills as the positives keep piling up for Resverlogix.
The company already said that most of the $87 million from Hepalink will be used to pay off the company's $68.8 million secured loan, so once that happens it means we should be seeing more news about the company being debt free.
They've already received 5 positive reccomendations from the independent Data Safety Monitoring Board for their Phase 3 trial of Apabetalone....the Futility Analysis should be out any time now.
And maybe there's liscensing news in the works as well.....lots to be excited about.